Clinical Trial Update: Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Niacin/Laropiprant on postprandial lipoprotein metabolism in patients with dyslipoproteinemia was terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia
• Metabolic Syndrome

Drugs mentioned

• Laropiprant (laropiprant)
• Niacin (nicotinic acid)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Hyperlipoproteinemia, Metabolic Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2014-04-10